The director of that group of Medicina Genómica del CiMUS de la Universidad de Santiago de Compostela (USC), Angel Carracedo, coordinates the mayor’s program of Medicina Genómica de España, which focuses on specific pathologies such as cancer, rare diseases and psychiatry.
The program, endowed with 7.25 million euros, as an objective facilitates assisted practice in all countries, agilizes diagnostics, treats and optimizes resources. Integrates into the IMPaCT Structural Action of the Carlos III Institute of Health, and is aligned with the European Initiative ‘A million genomes’, international action of great magnitude in which Spain will have a detached paper. “We are very delusional with this project that marks the truck present and the future of the development of personalized medicine in Spain”, Carracedo pointed out.
“This initiative has a key import for the National Health System (SNS)“that genomic medicine represents a revolution in sanitary assistance, to enable diagnostics, identify the best treatments and design prevention strategies”, he specified.
Therefore, the objective of the IMPaCT Program on Genome Medicine is to create a robust collaborative structure for the implementation of Genome Medicine in coordination with the SNS. In this way, patients of all autonomous communities (CCAAs) of Spain can access equity and adequate time to respond to all genomic tests that are accurate to increase their health, at the same time that genomic data are obtained that are .
Five genome analysis centers for genomic analysis
Specifically, the program will meet with a network of five genomic analysis centers and a group of clinical experts. Total, participant 45 groups of 38 centers (25 hospitals and 13 university research centers) with representatives of all the CCAAs.
The network of genomic analysis centers and the group of clinical experts will provide high-level genomic sequencing services, interpretation of the results and elaboration of a clinical information for the entire SNS, combining three examples of application: Diagnosis of rare diseases, somatic mutation in cancer and application of the pharmacogenetic in cancer and psychiatric diseases.
In addition, this program is coordinated with international initiatives such as the International Association of Rare Inquiries (IRDiRC) and the International Consortium of Genome of Cancer (ICGC) Assimismo, genomic analysis and other ‘omicos’ data in all the national territory, while supporting the technologies of ultimate generation and experience that exist for its application in the diagnosis of human diseases.
In essence, the project led by Carracedo is about to put the ‘experimental’ diagnostic technologies to service all those people who, while carrying out the diagnostic effort with maximum assistive technology, have no diagnostic available. Asi pues, supone “a basic step” to put the level of seniority in the service of the people and the SNS, says Carracedo.
Happiness in the Middle Ages, the Future
Follow the National Research Council, la personalized medicine and precision suppose the adaptation of the medical treatment to the individual characteristics of each patient, that is, the possibility of identifying patients that differ in their susceptibility to experimenting with a determined determinant, in the biology or prognosis of that procedure, or with the determination.
This identification is carried out through the analysis and integration of genomic data, other omniscient data, image techniques, with clinical data and the patient’s entourage. However, the possibility of applying therapeutic interventions, avoiding possible secondary effects, improving the efficacy of treatments, etc. is considered. Definitely, a change in the paradigm of how to apply medical assistance, andincorporates diagnostic and treatment strategies more efficient and secure.
Although it contains statements, dates or appointments of institutions or health care professionals, the information contained in Redacción Médica is edited and elaborated by periodicals. We recommend to the reader that any relationship with the health be consulted with a health care professional.